Therapeutic resistance of pancreatic cancer: Roadmap to its reversal
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Therapeutic resistance of pancreatic cancer: Roadmap to its reversal
Authors
Keywords
Pancreatic cancer, Chemotherapy, Radiotherapy, Immunotherapy, Therapeutic resistance
Journal
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
Volume 1875, Issue 1, Pages 188461
Publisher
Elsevier BV
Online
2020-11-04
DOI
10.1016/j.bbcan.2020.188461
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2020
- (2020) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Dilemma and Challenge of Immunotherapy for Pancreatic Cancer
- (2020) Jia Wu et al. DIGESTIVE DISEASES AND SCIENCES
- Metabolism of pancreatic cancer: paving the way to better anticancer strategies
- (2020) Cheng Qin et al. Molecular Cancer
- B cell–Derived IL35 Drives STAT3-Dependent CD8+ T-cell Exclusion in Pancreatic Cancer
- (2020) Bhalchandra Mirlekar et al. Cancer Immunology Research
- Early detection of pancreatic cancer
- (2020) Stephen P Pereira et al. Lancet Gastroenterology & Hepatology
- Immunotherapy for pancreatic cancer: A 2020 update
- (2020) Dimitrios Schizas et al. CANCER TREATMENT REVIEWS
- An engineered chimeric toxin that cleaves activated mutant and wild-type RAS inhibits tumor growth
- (2020) Vania Vidimar et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Carrier‐Free Nanoassembly of Curcumin–Erlotinib Conjugate for Cancer Targeted Therapy
- (2020) Chen Cheng et al. Advanced Healthcare Materials
- HIF-1-Dependent Reprogramming of Glucose Metabolic Pathway of Cancer Cells and Its Therapeutic Significance
- (2019) Ayako Nagao et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Acetyl-CoA metabolism supports multi-step pancreatic tumorigenesis
- (2019) Alessandro Carrer et al. Cancer Discovery
- Inhibition of HSP90 overcomes resistance to chemotherapy and radiotherapy in pancreatic cancer
- (2019) Ganji Purnachandra Nagaraju et al. INTERNATIONAL JOURNAL OF CANCER
- Macrophage-Released Pyrimidines Inhibit Gemcitabine Therapy in Pancreatic Cancer
- (2019) Christopher J. Halbrook et al. Cell Metabolism
- KRAS G12V Mutation in Acquired Resistance to Combined BRAF and MEK Inhibition in Papillary Thyroid Cancer
- (2019) Dwight H. Owen et al. Journal of the National Comprehensive Cancer Network
- Low CD8+ T Cell Infiltration and High PD-L1 Expression Are Associated with Level of CD44+/CD133+ Cancer Stem Cells and Predict an Unfavorable Prognosis in Pancreatic Cancer
- (2019) Ya-Chin Hou et al. Cancers
- Stromal Microenvironment Shapes the Intratumoral Architecture of Pancreatic Cancer
- (2019) Matteo Ligorio et al. CELL
- Radioresistance of KRAS/TP53‐Mutated Lung Cancer can be overcome by Radiation Dose Escalation or EGFR Tyrosine Kinase Inhibition In Vivo
- (2019) Kristin Gurtner et al. INTERNATIONAL JOURNAL OF CANCER
- Agonism of CD11b reprograms innate immunity to sensitize pancreatic cancer to immunotherapies
- (2019) Roheena Z. Panni et al. Science Translational Medicine
- Cross-Species Single-Cell Analysis of Pancreatic Ductal Adenocarcinoma Reveals Antigen-Presenting Cancer-Associated Fibroblasts
- (2019) Ela Elyada et al. Cancer Discovery
- Dual inhibition of the PI3K and MAPK pathways enhances nab-paclitaxel/gemcitabine chemotherapy response in preclinical models of pancreatic cancer
- (2019) Niranjan Awasthi et al. CANCER LETTERS
- Chemoresistance in Pancreatic Cancer
- (2019) Zeng et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Gemcitabine‐induced epithelial‐mesenchymal transition‐like changes sustain chemoresistance of pancreatic cancer cells of mesenchymal‐like phenotype
- (2019) Mehdi El Amrani et al. MOLECULAR CARCINOGENESIS
- Overexpression of DCLK1-AL Increases Tumor Cell Invasion, Drug Resistance, and KRAS Activation and Can Be Targeted to Inhibit Tumorigenesis in Pancreatic Cancer
- (2019) Dongfeng Qu et al. Journal of Oncology
- ZIP4 Increases Expression of Transcription Factor ZEB1 to Promote Integrin α3β1 Signaling and Inhibit Expression of the Gemcitabine Transporter ENT1 in Pancreatic Cancer Cells
- (2019) Mingyang Liu et al. GASTROENTEROLOGY
- Single-cell RNA sequencing reveals compartmental remodeling of tumor-infiltrating immune cells induced by anti-CD47 targeting in pancreatic cancer
- (2019) Yu Pan et al. Journal of Hematology & Oncology
- From state-of-the-art treatments to novel therapies for advanced-stage pancreatic cancer
- (2019) Christopher Nevala-Plagemann et al. Nature Reviews Clinical Oncology
- Dual-targeting of EGFR and Neuropilin-1 attenuates resistance to EGFR-targeted antibody therapy in KRAS-mutant non-small cell lung cancer
- (2019) Ye-Jin Kim et al. CANCER LETTERS
- New-Onset Diabetes, Longitudinal Trends in Metabolic Markers, and Risk of Pancreatic Cancer in a Heterogeneous Population
- (2019) Brian Z. Huang et al. Clinical Gastroenterology and Hepatology
- Intracellular cytidine deaminase regulates gemcitabine metabolism in pancreatic cancer cell lines
- (2019) Tormod K Bjånes et al. DRUG METABOLISM AND DISPOSITION
- Cytoplasmic HuR Status Predicts Disease-free Survival in Resected Pancreatic Cancer
- (2018) Talar Tatarian et al. ANNALS OF SURGERY
- Tumor–Stroma IL1β-IRAK4 Feedforward Circuitry Drives Tumor Fibrosis, Chemoresistance, and Poor Prognosis in Pancreatic Cancer
- (2018) Daoxiang Zhang et al. CANCER RESEARCH
- SMAD4Gene Mutation Renders Pancreatic Cancer Resistance to Radiotherapy through Promotion of Autophagy
- (2018) Feng Wang et al. CLINICAL CANCER RESEARCH
- Regulation and Function of the PD-L1 Checkpoint
- (2018) Chong Sun et al. IMMUNITY
- GRP78-mediated antioxidant response and ABC transporter activity confers chemoresistance to pancreatic cancer cells
- (2018) Patricia Dauer et al. Molecular Oncology
- Abrogation of glutathione peroxidase-1 drives EMT and chemoresistance in pancreatic cancer by activating ROS-mediated Akt/GSK3β/Snail signaling
- (2018) Qingcai Meng et al. ONCOGENE
- Stroma — A Double-Edged Sword in Pancreatic Cancer
- (2018) Jichun Gu et al. PANCREAS
- Tumor budding is a prognostic factor linked to epithelial mesenchymal transition in pancreatic ductal adenocarcinoma. Study report and literature review
- (2018) Ezzeddine Chouat et al. PANCREATOLOGY
- Local Blockade of Interleukin 10 and C-X-C Motif Chemokine Ligand 12 with Nano-Delivery Promotes Antitumor Response in Murine Cancers
- (2018) Limei Shen et al. ACS Nano
- Trials and tribulations of neoadjuvant therapy in pancreatic cancer
- (2018) M. Del Chiaro et al. BRITISH JOURNAL OF SURGERY
- Activation of KRAS Mediates Resistance to Targeted Therapy in MET Exon 14–mutant Non–small Cell Lung Cancer
- (2018) Ken Suzawa et al. CLINICAL CANCER RESEARCH
- Overcoming tumor hypoxia as a barrier to radiotherapy, chemotherapy and immunotherapy in cancer treatment
- (2018) Kaitlin Graham et al. International Journal of Nanomedicine
- Resistin effects on pancreatic cancer progression and chemoresistance are mediated through its receptors CAP1 and TLR4
- (2018) Min Zhang et al. JOURNAL OF CELLULAR PHYSIOLOGY
- The epithelial-to-mesenchymal transition induced by tumor-associated macrophages confers chemoresistance in peritoneally disseminated pancreatic cancer
- (2018) Kazuya Kuwada et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Fucoidan-Manganese Dioxide Nanoparticles Potentiate Radiation Therapy by Co-Targeting Tumor Hypoxia and Angiogenesis
- (2018) Sung-Won Shin et al. Marine Drugs
- FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer
- (2018) Thierry Conroy et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prolyl hydroxylase domain 3 influences the radiotherapy efficacy of pancreatic cancer cells by targeting hypoxia-inducible factor-1α
- (2018) Li-rui Tang et al. OncoTargets and Therapy
- Cancer-associated fibroblasts promote progression and gemcitabine resistance via the SDF-1/SATB-1 pathway in pancreatic cancer
- (2018) Lusheng Wei et al. Cell Death & Disease
- Inhibition of long non-coding RNA HOTAIR enhances radiosensitivity via regulating autophagy in pancreatic cancer
- (2018) Chunli Wu et al. Cancer Management and Research
- Mixed poly(vinyl pyrrolidone)-based drug-loaded nanomicelles shows enhanced efficacy against pancreatic cancer cell lines
- (2017) Anisha Veeren et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- LincRNA-p21 knockdown enhances radiosensitivity of hypoxic tumor cells by reducing autophagy through HIF-1/Akt/mTOR/P70S6K pathway
- (2017) Yueming Shen et al. EXPERIMENTAL CELL RESEARCH
- Up-regulation of glycolysis promotes the stemness and EMT phenotypes in gemcitabine-resistant pancreatic cancer cells
- (2017) Hengqiang Zhao et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Overcoming the resistance of pancreatic cancer to immune checkpoint inhibitors
- (2017) Richard A. Skelton et al. JOURNAL OF SURGICAL ONCOLOGY
- The MLL1-H3K4me3 Axis-Mediated PD-L1 Expression and Pancreatic Cancer Immune Evasion
- (2017) Chunwan Lu et al. JNCI-Journal of the National Cancer Institute
- Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial
- (2017) John P Neoptolemos et al. LANCET
- Functionalized nanoparticles enable tracking the rapid entry and release of doxorubicin in human pancreatic cancer cells
- (2017) Maheshika P. Arachchige et al. MICRON
- Epigenomic reprogramming during pancreatic cancer progression links anabolic glucose metabolism to distant metastasis
- (2017) Oliver G McDonald et al. NATURE GENETICS
- Pancreatic cancer heterogeneity and response to Mek inhibition
- (2017) K Pedersen et al. ONCOGENE
- FBW7 increases the chemosensitivity of pancreatic cancer cells to gemcitabine through upregulation of ENT1
- (2017) Qiangsheng Hu et al. ONCOLOGY REPORTS
- Inhibition of ATR potentiates the cytotoxic effect of gemcitabine on pancreatic cancer cells through enhancement of DNA damage and abrogation of ribonucleotide reductase induction by gemcitabine
- (2017) Shuang Liu et al. ONCOLOGY REPORTS
- Drugging RAS: Know the enemy
- (2017) Bjoern Papke et al. SCIENCE
- Roles of tumor heterogeneity in the development of drug resistance: A call for precision therapy
- (2017) Duojiao Wu et al. SEMINARS IN CANCER BIOLOGY
- Metabolic Interactions in the Tumor Microenvironment
- (2017) Costas A. Lyssiotis et al. TRENDS IN CELL BIOLOGY
- Collagen-derived proline promotes pancreatic ductal adenocarcinoma cell survival under nutrient limited conditions
- (2017) Orianne Olivares et al. Nature Communications
- m 6 A RNA Methylation Regulates the Self-Renewal and Tumorigenesis of Glioblastoma Stem Cells
- (2017) Qi Cui et al. Cell Reports
- KRAS: The Critical Driver and Therapeutic Target for Pancreatic Cancer
- (2017) Andrew M. Waters et al. Cold Spring Harbor Perspectives in Medicine
- The MLL1-H3K4me3 Axis-Mediated PD-L1 Expression and Pancreatic Cancer Immune Evasion
- (2017) Chunwan Lu et al. JNCI-Journal of the National Cancer Institute
- Update on the role of nanoliposomal irinotecan in the treatment of metastatic pancreatic cancer
- (2017) FNU Asad ur Rahman et al. Therapeutic Advances in Gastroenterology
- JAK-STAT-mediated chronic inflammation impairs cytotoxic T lymphocyte activation to decrease anti-PD-1 immunotherapy efficacy in pancreatic cancer
- (2017) Chunwan Lu et al. OncoImmunology
- Nanotechnologies in Pancreatic Cancer Therapy
- (2017) Ayesha Manzur et al. Pharmaceutics
- Chloroquine, an autophagy inhibitor, potentiates the radiosensitivity of glioma initiating cells by inhibiting autophagy and activating apoptosis
- (2016) Hongxing Ye et al. BMC Neurology
- Targeting Tumor-Associated Fibroblasts for Therapeutic Delivery in Desmoplastic Tumors
- (2016) Lei Miao et al. CANCER RESEARCH
- TGF-β-induced stromal CYR61 promotes resistance to gemcitabine in pancreatic ductal adenocarcinoma through downregulation of the nucleoside transporters hENT1 and hCNT3
- (2016) Rachel A. Hesler et al. CARCINOGENESIS
- Gemcitabine versus FOLFIRINOX in patients with advanced pancreatic adenocarcinoma hENT1-positive: everything was not too bad back when everything seemed worse
- (2016) A. Orlandi et al. Clinical & Translational Oncology
- Nanoparticle-siRNA: A potential cancer therapy?
- (2016) Samuel Wang Sherng Young et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- PANCREOX: A Randomized Phase III Study of Fluorouracil/Leucovorin With or Without Oxaliplatin for Second-Line Advanced Pancreatic Cancer in Patients Who Have Received Gemcitabine-Based Chemotherapy
- (2016) Sharlene Gill et al. JOURNAL OF CLINICAL ONCOLOGY
- Pancreatic cancer
- (2016) Terumi Kamisawa et al. LANCET
- Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global, randomised, open-label, phase 3 trial
- (2016) Andrea Wang-Gillam et al. LANCET
- Genomic analyses identify molecular subtypes of pancreatic cancer
- (2016) Peter Bailey et al. NATURE
- Targeting focal adhesion kinase renders pancreatic cancers responsive to checkpoint immunotherapy
- (2016) Hong Jiang et al. NATURE MEDICINE
- Therapeutic targeting of hypoxia and hypoxia-inducible factors in cancer
- (2016) Caroline Wigerup et al. PHARMACOLOGY & THERAPEUTICS
- Lysyl oxidase family activity promotes resistance of pancreatic ductal adenocarcinoma to chemotherapy by limiting the intratumoral anticancer drug distribution
- (2016) Benjamin Le Calvé et al. Oncotarget
- Paclitaxel and curcumin co-bound albumin nanoparticles having antitumor potential to pancreatic cancer
- (2016) Bomi Kim et al. Asian Journal of Pharmaceutical Sciences
- Impact of early disease progression and surgical complications on adjuvant chemotherapy completion rates and survival in patients undergoing the surgery first approach for resectable pancreatic ductal adenocarcinoma – A population-based cohort study
- (2015) Knut J. Labori et al. ACTA ONCOLOGICA
- Expression of E-cadherin repressors SNAIL, ZEB1 and ZEB2 by tumour and stromal cells influences tumour-budding phenotype and suggests heterogeneity of stromal cells in pancreatic cancer
- (2015) J A Galván et al. BRITISH JOURNAL OF CANCER
- Ibrutinib Exerts Potent Antifibrotic and Antitumor Activities in Mouse Models of Pancreatic Adenocarcinoma
- (2015) D. Masso-Valles et al. CANCER RESEARCH
- Cytidine Deaminase Axis Modulated by miR-484 Differentially Regulates Cell Proliferation and Chemoresistance in Breast Cancer
- (2015) F.-G. Ye et al. CANCER RESEARCH
- KRAS as a Therapeutic Target
- (2015) F. McCormick CLINICAL CANCER RESEARCH
- Targeting the LOX/hypoxia axis reverses many of the features that make pancreatic cancer deadly: inhibition of LOX abrogates metastasis and enhances drug efficacy
- (2015) Bryan W Miller et al. EMBO Molecular Medicine
- Pharmacological targeting of the protein synthesis mTOR/4E-BP1 pathway in cancer-associated fibroblasts abrogates pancreatic tumour chemoresistance
- (2015) C. Duluc et al. EMBO Molecular Medicine
- Randomized Phase Ib/II Study of Gemcitabine Plus Placebo or Vismodegib, a Hedgehog Pathway Inhibitor, in Patients With Metastatic Pancreatic Cancer
- (2015) Daniel V.T. Catenacci et al. JOURNAL OF CLINICAL ONCOLOGY
- Germline BRCA Mutations in a Large Clinic-Based Cohort of Patients With Pancreatic Adenocarcinoma
- (2015) Spring Holter et al. JOURNAL OF CLINICAL ONCOLOGY
- PD-1/PD-L1 Blockade Together With Vaccine Therapy Facilitates Effector T-Cell Infiltration Into Pancreatic Tumors
- (2015) Kevin C. Soares et al. JOURNAL OF IMMUNOTHERAPY
- Epithelial-to-mesenchymal transition is dispensable for metastasis but induces chemoresistance in pancreatic cancer
- (2015) Xiaofeng Zheng et al. NATURE
- PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
- (2015) Dung T. Le et al. NEW ENGLAND JOURNAL OF MEDICINE
- HES 1 is essential for chemoresistance induced by stellate cells and is associated with poor prognosis in pancreatic cancer
- (2015) FENG CAO et al. ONCOLOGY REPORTS
- Pancreatic cancer: The microenvironment needs attention too!
- (2015) M.V. Apte et al. PANCREATOLOGY
- Addressing the challenges of pancreatic cancer: Future directions for improving outcomes
- (2015) Manuel Hidalgo et al. PANCREATOLOGY
- Cholesterol uptake disruption, in association with chemotherapy, is a promising combined metabolic therapy for pancreatic adenocarcinoma
- (2015) Fabienne Guillaumond et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Site-specific processing of Ras and Rap1 Switch I by a MARTX toxin effector domain
- (2015) Irena Antic et al. Nature Communications
- Bruton Tyrosine Kinase-Dependent Immune Cell Cross-talk Drives Pancreas Cancer
- (2015) A. J. Gunderson et al. Cancer Discovery
- Inhibition of RAC1 GTPase sensitizes pancreatic cancer cells to γ-irradiation
- (2015) Ying Yan et al. Oncotarget
- Interdependence of Gemcitabine Treatment, Transporter Expression, and Resistance in Human Pancreatic Carcinoma Cells
- (2015) Wolfgang Hagmann et al. NEOPLASIA
- Efficacy of gemcitabine conjugated and miRNA-205 complexed micelles for treatment of advanced pancreatic cancer
- (2014) Anupama Mittal et al. BIOMATERIALS
- A chitosan-graft-PEI-candesartan conjugate for targeted co-delivery of drug and gene in anti-angiogenesis cancer therapy
- (2014) Xiuli Bao et al. BIOMATERIALS
- Unbiased analysis of pancreatic cancer radiation resistance reveals cholesterol biosynthesis as a novel target for radiosensitisation
- (2014) J J Souchek et al. BRITISH JOURNAL OF CANCER
- dCK expression correlates with 5-fluorouracil efficacy and HuR cytoplasmic expression in pancreatic cancer
- (2014) Florencia McAllister et al. CANCER BIOLOGY & THERAPY
- Depletion of Carcinoma-Associated Fibroblasts and Fibrosis Induces Immunosuppression and Accelerates Pancreas Cancer with Reduced Survival
- (2014) Berna C. Özdemir et al. CANCER CELL
- Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United States
- (2014) L. Rahib et al. CANCER RESEARCH
- CSF1/CSF1R Blockade Reprograms Tumor-Infiltrating Macrophages and Improves Response to T-cell Checkpoint Immunotherapy in Pancreatic Cancer Models
- (2014) Y. Zhu et al. CANCER RESEARCH
- Preparation, optimization and in vitro characterization of stearoyl-gemcitabine polymeric micelles: A comparison with its self-assembled nanoparticles
- (2014) Zahra Daman et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Drugging the undruggable RAS: Mission Possible?
- (2014) Adrienne D. Cox et al. NATURE REVIEWS DRUG DISCOVERY
- Molecular mechanisms of epithelial–mesenchymal transition
- (2014) Samy Lamouille et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Establishment of human pancreatic cancer gemcitabine-resistant cell line with ribonucleotide reductase overexpression
- (2014) CONGFEI WANG et al. ONCOLOGY REPORTS
- Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
- (2014) C. Bettegowda et al. Science Translational Medicine
- Preparation and evaluation of polyethyleneimine-single walled carbon nanotube conjugates as vectors for pancreatic cancer treatment
- (2014) Enrico Andreoli et al. Journal of Materials Chemistry B
- The association between the expression of solute carrier transporters and the prognosis of pancreatic cancer
- (2013) Beatrice Mohelnikova-Duchonova et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- A Phase I Study of an Agonist CD40 Monoclonal Antibody (CP-870,893) in Combination with Gemcitabine in Patients with Advanced Pancreatic Ductal Adenocarcinoma
- (2013) G. L. Beatty et al. CLINICAL CANCER RESEARCH
- Nanoliposome-based antibacterial drug delivery
- (2013) Somayeh Hallaj-Nezhadi et al. DRUG DELIVERY
- MicroRNA 23b Regulates Autophagy Associated With Radioresistance of Pancreatic Cancer Cells
- (2013) Peng Wang et al. GASTROENTEROLOGY
- Evaluation of Ipilimumab in Combination With Allogeneic Pancreatic Tumor Cells Transfected With a GM-CSF Gene in Previously Treated Pancreatic Cancer
- (2013) Dung T. Le et al. JOURNAL OF IMMUNOTHERAPY
- Signatures of mutational processes in human cancer
- (2013) Ludmil B. Alexandrov et al. NATURE
- Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
- (2013) Daniel D. Von Hoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Macrophages mediate gemcitabine resistance of pancreatic adenocarcinoma by upregulating cytidine deaminase
- (2013) N Weizman et al. ONCOGENE
- CTGF antagonism with mAb FG-3019 enhances chemotherapy response without increasing drug delivery in murine ductal pancreas cancer
- (2013) A. Neesse et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Serum carbohydrate antigen 19-9 represents a marker of response to neoadjuvant therapy in patients with borderline resectable pancreatic cancer
- (2013) Ching-Wei D. Tzeng et al. HPB
- Concentrative nucleoside transporter 1 (hCNT1) promotes phenotypic changes relevant to tumor biology in a translocation-independent manner
- (2013) S Pérez-Torras et al. Cell Death & Disease
- Value of Carbohydrate Antigen 19-9 in Predicting Response and Therapy Control in Patients with Metastatic Pancreatic Cancer Undergoing First-Line Therapy
- (2013) Uwe Pelzer et al. Frontiers in Oncology
- CA19-9 in Potentially Resectable Pancreatic Cancer: Perspective to Adjust Surgical and Perioperative Therapy
- (2012) Werner Hartwig et al. ANNALS OF SURGICAL ONCOLOGY
- Carbohydrate antigen 19-9 is a prognostic and predictive biomarker in patients with advanced pancreatic cancer who receive gemcitabine-containing chemotherapy
- (2012) Todd M. Bauer et al. CANCER
- Enzymatic Targeting of the Stroma Ablates Physical Barriers to Treatment of Pancreatic Ductal Adenocarcinoma
- (2012) Paolo P. Provenzano et al. CANCER CELL
- Targeted destruction of the orchestration of the pancreatic stroma and tumor cells in pancreatic cancer cases: Molecular basis for therapeutic implications
- (2012) Xiangyu Kong et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Hyaluronan impairs vascular function and drug delivery in a mouse model of pancreatic cancer
- (2012) Michael A Jacobetz et al. GUT
- Inhibition of hedgehog signaling depresses self-renewal of pancreatic cancer stem cells and reverses chemoresistance
- (2012) FENG-TING HUANG et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Inclusion Complex of Novel Curcumin Analogue CDF and β-Cyclodextrin (1:2) and Its Enhanced In Vivo Anticancer Activity Against Pancreatic Cancer
- (2012) Prasad R. Dandawate et al. PHARMACEUTICAL RESEARCH
- Inhibition of Non-Homologous End Joining Repair Impairs Pancreatic Cancer Growth and Enhances Radiation Response
- (2012) Ying-Hua Li et al. PLoS One
- MUC1 mucin stabilizes and activates hypoxia-inducible factor 1 alpha to regulate metabolism in pancreatic cancer
- (2012) N. V. Chaika et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- ABC Proteins Protect the Human Body and Maintain Optimal Health
- (2011) Kazumitsu UEDA BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY
- A novel method for quantification of gemcitabine and its metabolites 2′,2′-difluorodeoxyuridine and gemcitabine triphosphate in tumour tissue by LC–MS/MS: comparison with 19F NMR spectroscopy
- (2011) Tashinga E. Bapiro et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- CNT1 Expression Influences Proliferation and Chemosensitivity in Drug-Resistant Pancreatic Cancer Cells
- (2011) Y. D. Bhutia et al. CANCER RESEARCH
- Notch Signaling Activated by Replication Stress-Induced Expression of Midkine Drives Epithelial-Mesenchymal Transition and Chemoresistance in Pancreatic Cancer
- (2011) C. Gungor et al. CANCER RESEARCH
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Polymer–drug conjugates as nano-sized medicines
- (2011) Fabiana Canal et al. CURRENT OPINION IN BIOTECHNOLOGY
- Best supportive care (BSC) versus oxaliplatin, folinic acid and 5-fluorouracil (OFF) plus BSC in patients for second-line advanced pancreatic cancer: A phase III-study from the German CONKO-study group
- (2011) Uwe Pelzer et al. EUROPEAN JOURNAL OF CANCER
- Diabetes mellitus and risk of pancreatic cancer: A meta-analysis of cohort studies
- (2011) Qiwen Ben et al. EUROPEAN JOURNAL OF CANCER
- Dynamics of DNA damage response proteins at DNA breaks: a focus on protein modifications
- (2011) S. E. Polo et al. GENES & DEVELOPMENT
- Distribution and Clinical Significance of Th17 Cells in the Tumor Microenvironment and Peripheral Blood of Pancreatic Cancer Patients
- (2011) Songbing He et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Gemcitabine Plusnab-Paclitaxel Is an Active Regimen in Patients With Advanced Pancreatic Cancer: A Phase I/II Trial
- (2011) Daniel D. Von Hoff et al. JOURNAL OF CLINICAL ONCOLOGY
- Subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapy
- (2011) Eric A Collisson et al. NATURE MEDICINE
- FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
- (2011) Thierry Conroy et al. NEW ENGLAND JOURNAL OF MEDICINE
- CD40 Agonists Alter Tumor Stroma and Show Efficacy Against Pancreatic Carcinoma in Mice and Humans
- (2011) G. L. Beatty et al. SCIENCE
- MicroRNA-21 in Pancreatic Cancer: Correlation with Clinical Outcome and Pharmacologic Aspects Underlying Its Role in the Modulation of Gemcitabine Activity
- (2010) Elisa Giovannetti et al. CANCER RESEARCH
- HIF-1 and NDRG2 contribute to hypoxia-induced radioresistance of cervical cancer Hela cells
- (2010) Junye Liu et al. EXPERIMENTAL CELL RESEARCH
- Adjuvant Chemotherapy With Fluorouracil Plus Folinic Acid vs Gemcitabine Following Pancreatic Cancer Resection
- (2010) John P. Neoptolemos et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- In Vitro and In Vivo Anticancer Activity of a Novel Nano-sized Formulation Based on Self-assembling Polymers Against Pancreatic Cancer
- (2010) Clare Hoskins et al. PHARMACEUTICAL RESEARCH
- Epidermal growth factor receptor regulates pancreatic fibrosis
- (2009) Stacy A. Blaine et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- The Role of HuR in Gemcitabine Efficacy in Pancreatic Cancer: HuR Up-regulates the Expression of the Gemcitabine Metabolizing Enzyme Deoxycytidine Kinase
- (2009) C. L. Costantino et al. CANCER RESEARCH
- The Role of Tumor Cell-Derived Connective Tissue Growth Factor (CTGF/CCN2) in Pancreatic Tumor Growth
- (2009) K. L. Bennewith et al. CANCER RESEARCH
- Epithelial to Mesenchymal Transition Contributes to Drug Resistance in Pancreatic Cancer
- (2009) T. Arumugam et al. CANCER RESEARCH
- Heterogeneity in Cancer: Cancer Stem Cells versus Clonal Evolution
- (2009) Mark Shackleton et al. CELL
- Serum REG4 Level Is a Predictive Biomarker for the Response to Preoperative Chemoradiotherapy in Patients With Pancreatic Cancer
- (2009) Hidetoshi Eguchi et al. PANCREAS
- New Difluoro Knoevenagel Condensates of Curcumin, Their Schiff Bases and Copper Complexes as Proteasome Inhibitors and Apoptosis Inducers in Cancer Cells
- (2009) Subhash Padhye et al. PHARMACEUTICAL RESEARCH
- Inhibition of Hedgehog Signaling Enhances Delivery of Chemotherapy in a Mouse Model of Pancreatic Cancer
- (2009) K. P. Olive et al. SCIENCE
- Targeted Delivery of Gemcitabine to Pancreatic Adenocarcinoma Using Cetuximab as a Targeting Agent
- (2008) C. R. Patra et al. CANCER RESEARCH
- 14-3-3 Modulates Pancreatic Cancer Cell Survival and Invasiveness
- (2008) D. Neupane et al. CLINICAL CANCER RESEARCH
- Sonic Hedgehog Promotes Desmoplasia in Pancreatic Cancer
- (2008) J. M. Bailey et al. CLINICAL CANCER RESEARCH
- Styrene Maleic Acid-Pirarubicin Disrupts Tumor Microcirculation and Enhances the Permeability of Colorectal Liver Metastases
- (2008) Jurstine Daruwalla et al. JOURNAL OF VASCULAR RESEARCH
- LY2109761, a novel transforming growth factor receptor type I and type II dual inhibitor, as a therapeutic approach to suppressing pancreatic cancer metastasis
- (2008) D. Melisi et al. MOLECULAR CANCER THERAPEUTICS
- Serum CA19-9 Decline Compared to Radiographic Response as a Surrogate for Clinical Outcomes in Patients With Metastatic Pancreatic Cancer Receiving Chemotherapy
- (2008) Derrick Wong et al. PANCREAS
- Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses
- (2008) S. Jones et al. SCIENCE
- 2-Deoxy-d-glucose causes cytotoxicity, oxidative stress, and radiosensitization in pancreatic cancer
- (2007) Mitchell C. Coleman et al. FREE RADICAL BIOLOGY AND MEDICINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now